CD4 and malignant pleural mesothelioma: In non–small cell lung cancer (NSCLC), malignant pleural mesothelioma (45) and melanoma (46), EM-like CD4 T cells (47) and/or CD8 TEMRA at baseline were associated with response to ICI.